Abiopharma

Clinical trial NCT07681271 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-29 → 2026-07-30

Clinical trial NCT05296447 updates: 1. phase: not set → PHASE2 2. completion date: 2028-05-01 → 2031-06-01 3. primary completion date: 2028-05-01 → 2031-06-01 4. study type: OBSERVATIONAL → INTERVENTIONAL 5. allocation: not set → NON_RANDOMIZED 6. intervention model: not set → PARALLEL 7. primary purpose: not set → TREATMENT 8. …

Clinical trial NCT07102433 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2026-07-31 → 2026-09-30 3. primary completion date: 2026-07-31 → 2026-09-30

Clinical trial NCT07178730: start date: 2026-06-30 → 2026-08-30.

Clinical trial NCT07712874: start date: 2026-08-07 → 2026-08-10.

Clinical trial NCT06984341 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. enrollment: 162 → 0 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05176483 updates: 1. primary completion date: 2030-06-28 → 2027-01-31 2. enrollment: 1314 → 1394 participants 3. allocation: NON_RANDOMIZED → RANDOMIZED

Clinical trial NCT07028749 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. completion date: 2026-12-01 → 2028-04-01 3. primary completion date: 2026-07-01 → 2027-11-01 4. enrollment: 216 → 316 participants

Clinical trial NCT06822426 updates: 1. completion date: 2027-01-01 → 2028-01-01 2. primary completion date: 2027-01-01 → 2028-01-01

Clinical trial NCT07346066 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-03-31 → 2026-05-14

Clinical trial NCT04840563 updates: 1. allocation: RANDOMIZED → NA 2. intervention model: CROSSOVER → SINGLE_GROUP 3. primary purpose: TREATMENT → BASIC_SCIENCE 4. masking: DOUBLE → NONE

Clinical trial NCT07594106 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-25 → 2026-07-20 3. completion date: 2030-09-20 → 2030-10-27 4. primary completion date: 2030-09-20 → 2030-10-27

Clinical trial NCT06330064 updates: 1. phase: PHASE2 → PHASE1 2. enrollment: 520 → 680 participants

Clinical trial NCT01449409: completion date: 2024-12-31 → 2026-12-31.

Clinical trial NCT06160752: status: RECRUITING → ACTIVE_NOT_RECRUITING.